- Home
- LSTA vs SURG Comparison
LSTA vs SURG Comparison
Compare LSTA & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- SURG
- Stock Information
- Founded
- LSTA 1980
- SURG 2006
- Country
- LSTA United States
- SURG United States
- Employees
- LSTA N/A
- SURG N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- SURG Advertising
- Sector
- LSTA Health Care
- SURG Consumer Discretionary
- Exchange
- LSTA Nasdaq
- SURG Nasdaq
- Market Cap
- LSTA 20.9M
- SURG 56.5M
- IPO Year
- LSTA N/A
- SURG N/A
- Fundamental
- Price
- LSTA $2.80
- SURG $3.16
- Analyst Decision
- LSTA Strong Buy
- SURG Strong Buy
- Analyst Count
- LSTA 1
- SURG 1
- Target Price
- LSTA $15.00
- SURG $9.00
- AVG Volume (30 Days)
- LSTA 14.5K
- SURG 103.4K
- Earning Date
- LSTA 08-11-2025
- SURG 08-12-2025
- Dividend Yield
- LSTA N/A
- SURG N/A
- EPS Growth
- LSTA N/A
- SURG N/A
- EPS
- LSTA N/A
- SURG N/A
- Revenue
- LSTA $1,000,000.00
- SURG $40,029,467.00
- Revenue This Year
- LSTA N/A
- SURG $57.76
- Revenue Next Year
- LSTA N/A
- SURG $112.61
- P/E Ratio
- LSTA N/A
- SURG N/A
- Revenue Growth
- LSTA N/A
- SURG N/A
- 52 Week Low
- LSTA $1.87
- SURG $1.05
- 52 Week High
- LSTA $4.20
- SURG $3.47
- Technical
- Relative Strength Index (RSI)
- LSTA 59.64
- SURG 58.30
- Support Level
- LSTA $2.36
- SURG $2.64
- Resistance Level
- LSTA $2.69
- SURG $2.95
- Average True Range (ATR)
- LSTA 0.22
- SURG 0.21
- MACD
- LSTA 0.02
- SURG 0.03
- Stochastic Oscillator
- LSTA 62.50
- SURG 60.98
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.